Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Sitagliptin | Methyl 3-oxo-4-(2, 4, 5-trifluorophenyl)butanoate | VE009010 | View CAS 769195-26-8 |
Sitagliptin | Methyl 4-(2, 4-difluorophenyl)-3-oxobutanoate | VE009113 | View |
Sitagliptin | Methyl 4-(2, 5-difluorophenyl)-3-oxobutanoate | VE009112 | View |
Sitagliptin | Methyl 4-(3, 4-difluorophenyl)-3-oxobutanoate | VE009002 | View |
Sitagliptin | N, N'-(Ethane-1, 2-diyl)bis(3-amino-4-(2, 4, 5-trifluorophenyl)butanamide) Dihydrochloride | VE008996 | View |
Sitagliptin | N-butanoyl Sitagliptin | VE009114 | View |
Sitagliptin | Oxo Sitagliptin | VE008998 | View |
Sitagliptin | Oxo-N-Boc Sitagliptin | VE009003 | View |
Sitagliptin | Sitagliptin 1, 2, 4-Trifluorobenzene | VE006177 | View CAS 367-23-7 |
Sitagliptin | Sitagliptin 2 4 Difluorophenylaetic acid | VL201004 | View CAS 81228-09-3 |
Sitagliptin | Sitagliptin 2 5 difluoro phenyl acetic acid | VL201003 | View CAS 85068-27-5 |
Sitagliptin | Sitagliptin 2, 3, 6-Trifluorophenylacetic acid | VE006178 | View CAS 114152-23-7 |
Sitagliptin | Sitagliptin 2-Chloro Hydrazide Impurity | VL201026 | View |
Sitagliptin | Sitagliptin 2-Desfluoro Impurity | VE009000 | View CAS 486459-88-5 |
Sitagliptin | Sitagliptin 3-4 Difluorophenyl Acetic Acid | VL201002 | View CAS 658-93-5 |
Sitagliptin | Sitagliptin Acid | VE006432 | View CAS 936630-57-8 |
Sitagliptin | Sitagliptin Acid Impurity | VL201013 | View CAS 1204818-19-8 |
Sitagliptin | Sitagliptin BOC Butanoic Acid | VL201036 | View |
Sitagliptin | Sitagliptin Dimer Impurity | VL201028 | View CAS 2072867-07-1 |
Sitagliptin | Sitagliptin Dioxo Impurity | VL201016 | View CAS 764667-64-3 |
Sitagliptin | Sitagliptin Dioxo Impurity (Sodium Salt) | VE006424 | View |
Sitagliptin | Sitagliptin EP Impurity A | VE006598 | View CAS 823817-55-6 |
Sitagliptin | Sitagliptin EP Impurity A (HCl salt) | VL201001 | View |
Sitagliptin | Sitagliptin EP Impurity A (Phosphate Salt) | VE006482 | View CAS (823817-58-9) |
Sitagliptin | Sitagliptin EP Impurity B | VL201006 | View CAS 1345822-87-8 |
Sitagliptin | Sitagliptin EP Impurity B (Phosphate Salt) | VL201032 | View |
Sitagliptin | Sitagliptin EP Impurity C | VL201005 | View CAS 1345822-86-7 |
Sitagliptin | Sitagliptin EP Impurity C (Phosphate Salt) | VL201031 | View |
Sitagliptin | Sitagliptin Enamine Impurity | VL201014 | View CAS 767340-03-4 |
Sitagliptin | Sitagliptin Fumarate Adduct | VL201021 | View CAS 2088771-60-0 |
Sitagliptin | Sitagliptin Hydroxy Amide Impurity | VE008997 | View CAS 1253056-01-7 |
Sitagliptin | Sitagliptin Imidazole Derivative | VE008964 | View CAS 1364122-90-6 |
Sitagliptin | Sitagliptin Impurity 1 | VL201008 | View |
Sitagliptin | Sitagliptin Impurity 4 | VL201011 | View CAS 486460-23-5 |
Sitagliptin | Sitagliptin Impurity F (In House) | VL201022 | View |
Sitagliptin | Sitagliptin Keto Amide Impurity | VL201015 | View CAS 764667-65-4 |
Sitagliptin | Sitagliptin N-Acetyl Impurity | VE008598 | View CAS 1379666-94-0 |
Sitagliptin | Sitagliptin N-Formyl Impurity | VE006565 | View |
Sitagliptin | Sitagliptin Phenyl Crotonyl Analog | VL201025 | View CAS 1253056-18-6 |
Sitagliptin | Sitagliptin Pyrazinone Impurity | VE009001 | View CAS 877402-45-4 |
Sitagliptin | Sitagliptin Styrylacetyl Analog | VL201024 | View CAS 1803026-58-5 |
Sitagliptin | Sitagliptin Tartrate Hemihydrate | VL201020 | View |
Sitagliptin | Sitagliptin Triazecine Analog | VL201018 | View CAS 2088771-61-1 |
Sitagliptin | Sitagliptin Triazole Impurity | VL201012 | View |
Sitagliptin | Tert-Butyl 3-(Trifluoromethyl)-5, 6-dihydro-[1, 2, 4]triazolo[4, 3-a]pyrazine-7(8H)-carboxylate | VE009004 | View CAS 877402-43-2 |
Sitagliptin | Tert-Butyl 8-Oxo-3-(trifluoromethyl)-5, 6-dihydro-[1, 2, 4]triazolo[4, 3-a]pyrazine-7(8H)-carboxylate | VE009006 | View CAS 877402-44-3 |
Sitagliptin | 2, 3, 4-Trifluorophenylacetic Acid | VE008129 | View CAS 243666-12-8 |
Sitagliptin | 2, 3, 5-Trifluorophenylacetic Acid | VE008130 | View CAS 132992-28-0 |
Sitagliptin | 2, 4, 5-Trifluorobenzyl chloride | VE006099 | View CAS 243139-71-1 |
Sitagliptin | 2, 4, 6-Trifluorophenylacetic Acid | VE008131 | View CAS 209991-63-9 |
Sitagliptin | 2-desfluoro N-Boc methyl ester Impurity | VE008999 | View |
Sitagliptin | 3-Hydroxy-3, 4-Dicaboxy-Butanamide-N-Hexanoic Acid | VL201023 | View |
Sitagliptin | 5-(2-(2, 5-difluorophenyl)-1-hydroxyethylidene)-2, 2-dimethyl-1, 3-dioxane-4, 6-dione | VE009007 | View CAS 764667-66-5 |
Sitagliptin | 5-(Trifluoromethyl)-2-(chloromethyl)-1, 3, 4-oxadiazole | VE0010888 | View CAS 723286-98-4 |
Sitagliptin | (2Z)-1-[5, 6-Dihydro-3-(trifluoromethyl)-1, 2, 4-triazolo[4, 3-a]pyrazin-7(8H)-yl]-4-(2, 4, 5-trifluorophenyl)-2-buten-1-one | VE008780 | View CAS 1803026-54-1 |
Sitagliptin | (3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2, 4-difluorophenyl)butanoic Acid | VE009008 | View CAS 851307-12-5 |
Sitagliptin | (E)-1-(3-(trifluoromethyl)-5, 6-dihydro-[1, 2, 4]triazolo[4, 3-a]pyrazin-7(8H)-yl)-4-(2, 4, 5-trifluorophenyl)but-2-en-1-one | VE009354 | View |
Sitagliptin | (R)-Sitagliptin Methyl-Ester Impurity | VL201034 | View CAS 881995-69-3 |
Sitagliptin | (R)-Sitagliptin Methyl-Ester Impurity (HCl Salt) | VE008550 | View CAS 1374985-05-3 |
Sitagliptin | (R)-Sitagliptin N-Boc-Methyl-Ester Impurity | VE006048 | View CAS 881995-73-9 |
Sitagliptin | (S)-Sitagliptin N-Boc-Acid Impurity | VL201030 | View CAS 922178-94-7 |
Sitagliptin | (Z)-2, 2, 2-trifluoro-N'-(piperazin-2-ylidene)acetohydrazide | VE0010889 | View CAS 763105-70-0 |
Sitagliptin Related Compound
Sitagliptin is a type of diabetic medication. Type 2 diabetes is a condition in which the body does not produce enough insulin or the insulin produced does not function correctly. This might result in elevated blood sugar levels (hyperglycaemia).
References
- Kesavadev, Jothydev, et al. “Sitagliptin 100 Mg vs Glimepiride 1–3 Mg as an Add-on to Insulin and Metformin in Type 2 Diabetes (SWIM).” Endocrine Connections, vol. 6, no. 8, Nov. 2017, pp. 748–57, https://doi.org/10.1530/ec-17-0100.
- Wikipedia Contributors. “Sitagliptin.” Wikipedia, Wikimedia Foundation, 2 Nov. 2022, en.wikipedia.org/wiki/Sitagliptin#Mechanism_of_action.
- Sitagliptin and Metformin (Oral Route) Description and Brand Names – Mayo Clinic.” Mayoclinic.org, 2023, www.mayoclinic.org/drugs-supplements/sitagliptin-and metformin-oral-route/description/drug
FAQ’s
What is the mechanisms of action of sitagliptin?
Sitagliptin acts by inhibiting the enzyme dipeptidyl peptidase 4 competitively (DPP-4). This enzyme degrades the gastrointestinal hormones GLP-1 and GIP, which are secreted in response to a meal. By blocking the breakdown of GLP-1 and GIP, they are able to boost insulin production while suppressing glucagon release by pancreatic alpha cells.
In what combination is sitagliptin administered?
Metformin and sitagliptin are used together to treat type 2 diabetes-related elevated bloodsugar levels. Metformin inhibits sugar absorption from the stomach, decreases the release ofstored sugar from the liver, and improves your body’s use of sugar.